Published in Carcinogenesis on February 01, 2007
Role of mutagenicity in asbestos fiber-induced carcinogenicity and other diseases. J Toxicol Environ Health B Crit Rev (2011) 0.98
Non-neoplastic and neoplastic pleural endpoints following fiber exposure. J Toxicol Environ Health B Crit Rev (2011) 0.94
Syntenic relationships between genomic profiles of fiber-induced murine and human malignant mesothelioma. Am J Pathol (2011) 0.81
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Advances in malignant mesothelioma. N Engl J Med (2005) 8.50
An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods (2001) 6.68
Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2. Genes Dev (2000) 2.72
Long-term health effects in hamsters and rats exposed chronically to man-made vitreous fibres. Ann Occup Hyg (1987) 2.23
TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer. IARC Sci Publ (2004) 2.23
TP53 and liver carcinogenesis. Hum Mutat (2003) 2.23
Genetic alterations in cancer knowledge system: analysis of gene mutations in mouse and human liver and lung tumors. Toxicol Sci (2006) 1.43
Asbestos, chromosomal deletions, and tumor suppressor gene alterations in human malignant mesothelioma. J Cell Physiol (1999) 1.38
Establishment of a murine model of malignant mesothelioma. Int J Cancer (1992) 1.35
Man-made vitreous fibres. IARC Monogr Eval Carcinog Risks Hum (2002) 1.26
p53 gene mutations inside and outside of exons 5-8: the patterns differ in breast and other cancers. Oncogene (1995) 1.13
Hemizygosity of Nf2 is associated with increased susceptibility to asbestos-induced peritoneal tumours. Oncogene (2003) 0.98
Molecular profiling of malignant peritoneal mesothelioma identifies the ubiquitin-proteasome pathway as a therapeutic target in poor prognosis tumors. Oncogene (2006) 0.91
Distinct spectrum of mutations induced by crocidolite asbestos: clue for 8-hydroxydeoxyguanosine-dependent mutagenesis in vivo. Cancer Res (2002) 0.91
Similar tumor suppressor gene alteration profiles in asbestos-induced murine and human mesothelioma. Cell Cycle (2005) 0.89
Inactivations of p16INK4a-alpha, p16INK4a-beta and p15INK4b genes in 2',3'-dideoxycytidine- and 1,3-butadiene-induced murine lymphomas. Oncogene (1998) 0.84
Mesothelioma associated with environmental exposures. Med Lav (2006) 0.83
Superoxide anion release by alveolar macrophages exposed to respirable industrial fibres: modifying effect of fibre opsonisation. Exp Toxicol Pathol (1995) 0.82
Studies on the chronic toxicity (inhalation) of four types of refractory ceramic fiber in male Fischer 344 rats. Inhal Toxicol (1995) 0.82
An epidemiological study of the respiratory health of workers in the European refractory ceramic fibre industry. Occup Environ Med (2001) 0.82
The chemiluminescent response from human monocyte-derived macrophages exposed to various mineral fibers of different sizes. Ind Health (2000) 0.82
Multiple-dose chronic inhalation toxicity study of size-separated kaolin refractory ceramic fiber in male Fischer 344 rats. Inhal Toxicol (1995) 0.81
Analysis of K-ras and p53 mutations in mesotheliomas from humans and rats exposed to asbestos. Mutat Res (2000) 0.81
DNA fingerprint analysis reveals differences in mutational patterns in experimentally induced rat peritoneal tumors, depending on the type of environmental mutagen. Cancer Genet Cytogenet (1999) 0.78
Cytotoxicity of refractory ceramic fibres to Chinese hamster ovary cells in culture. Toxicol In Vitro (1992) 0.77
Biological effects of man-made mineral fibers (II)--their genetic damages examined by in vitro assay. Ind Health (1999) 0.77
Biological effects of man-made mineral fibers (I)--Reactive oxygen species production and calcium homeostasis in alveolar macrophages. Ind Health (1999) 0.77
P53 mutations in tumours induced by intraperitoneal injection of crocidolite asbestos and benzo[a]pyrene in rats. Exp Toxicol Pathol (1997) 0.77
Multifocal intrafollicular granulosa cell tumor of the ovary associated with an unusual germline p53 mutation. Mod Pathol (2004) 0.77
Release of metal particles from needles used for transbronchial needle aspiration. Chest (2010) 2.70
Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report. Biol Blood Marrow Transplant (2006) 2.63
Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS). Arthritis Rheum (2004) 2.44
Targeting calcineurin activation as a therapeutic strategy for T-cell acute lymphoblastic leukemia. Nat Med (2007) 2.28
Activated eosinophils in upper gastrointestinal tract of patients with graft-versus-host disease. Blood (2002) 2.08
Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimen. PLoS Med (2007) 2.00
FGFR3 and TP53 gene mutations define two distinct pathways in urothelial cell carcinoma of the bladder. Cancer Res (2003) 1.64
Binding of Escherichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class I-related molecule MICA. Proc Natl Acad Sci U S A (2002) 1.63
Rituximab plus CHOP (R-CHOP) overcomes PRDM1-associated resistance to chemotherapy in patients with diffuse large B-cell lymphoma. Blood (2007) 1.59
Stress-induced disruption of colonic epithelial barrier: role of interferon-gamma and myosin light chain kinase in mice. Gastroenterology (2003) 1.53
Characterization of endogenous human promyelocytic leukemia isoforms. Cancer Res (2006) 1.52
Oxidative stress and proinflammatory effects of carbon black and titanium dioxide nanoparticles: role of particle surface area and internalized amount. Toxicology (2009) 1.46
Angiotropic neonatal congenital melanocytic nevus: how extravascular migration of melanocytes may explain the development of congenital nevi. Am J Dermatopathol (2010) 1.46
The role of the pathologist in tissue banking: European Consensus Expert Group Report. Virchows Arch (2010) 1.44
In situ eosinophil activation in 26 primary cutaneous T-cell lymphomas with blood eosinophilia. J Am Acad Dermatol (2005) 1.44
Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse. Genes Dev (2002) 1.43
Endothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle-cell disease. J Clin Invest (2008) 1.42
An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation. J Immunol (2008) 1.34
Vaccination-induced cutaneous pseudolymphoma. J Am Acad Dermatol (2005) 1.33
TP53 status and response to chemotherapy in breast cancer. Pathobiology (2008) 1.28
Th17/Treg ratio in human graft-versus-host disease. Blood (2010) 1.19
Overexpression of endocan induces tumor formation. Cancer Res (2003) 1.19
Class III beta-tubulin expression predicts prostate tumor aggressiveness and patient response to docetaxel-based chemotherapy. Cancer Res (2010) 1.18
Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation. Cancer (2008) 1.17
Chronic recurrent lymphocytic Sweet syndrome as a predictive marker of myelodysplasia: a report of 9 cases. Arch Dermatol (2006) 1.16
The NF-kappaB/IL-6 pathway in metastatic androgen-independent prostate cancer: new therapeutic approaches? World J Urol (2007) 1.13
Mesothelioma: Do asbestos and carbon nanotubes pose the same health risk? Part Fibre Toxicol (2009) 1.10
Vascular endothelial growth factor-A is expressed both on lymphoma cells and endothelial cells in angioimmunoblastic T-cell lymphoma and related to lymphoma progression. Lab Invest (2004) 1.07
Imatinib mesylate as a preoperative therapy in dermatofibrosarcoma: results of a multicenter phase II study on 25 patients. Clin Cancer Res (2010) 1.07
Mutations in TP53, but not FGFR3, in urothelial cell carcinoma of the bladder are influenced by smoking: contribution of exogenous versus endogenous carcinogens. Carcinogenesis (2004) 1.07
p53 in breast cancer subtypes and new insights into response to chemotherapy. Breast (2013) 1.05
Prognostic value of apoptotic cells and infiltrating neutrophils in graft-versus-host disease of the gastrointestinal tract in humans: TNF and Fas expression. Blood (2003) 1.05
In vivo activation of cAMP signaling induces growth arrest and differentiation in acute promyelocytic leukemia. J Exp Med (2002) 1.04
Inhaled nitric oxide protects transgenic SAD mice from sickle cell disease-specific lung injury induced by hypoxia/reoxygenation. Blood (2003) 1.02
BCL-2 and mutant NRAS interact physically and functionally in a mouse model of progressive myelodysplasia. Cancer Res (2007) 1.02
Donor-derived cells and human graft-versus-host disease of the skin. Blood (2006) 1.01
p53 dependent cell-cycle arrest triggered by chemotherapy in xenografted breast tumors. Int J Cancer (2009) 1.01
Clinical and histological characteristics of renal AA amyloidosis: a retrospective study of 68 cases with a special interest to amyloid-associated inflammatory response. Hum Pathol (2007) 1.00
TP53 status and response to treatment in breast cancers. J Biomed Biotechnol (2011) 0.99
In vitro effects of nanoparticles on renal cells. Part Fibre Toxicol (2008) 0.99
Blocking IL-21 signaling ameliorates xenogeneic GVHD induced by human lymphocytes. Blood (2011) 0.98
Protection against myocardial infarction and no-reflow through preservation of vascular integrity by angiopoietin-like 4. Circulation (2011) 0.98
Role of mutagenicity in asbestos fiber-induced carcinogenicity and other diseases. J Toxicol Environ Health B Crit Rev (2011) 0.98
Hemizygosity of Nf2 is associated with increased susceptibility to asbestos-induced peritoneal tumours. Oncogene (2003) 0.98
Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia. J Exp Med (2010) 0.98
Active chronic sarcoidosis is characterized by increased transitional blood B cells, increased IL-10-producing regulatory B cells and high BAFF levels. PLoS One (2012) 0.98
Breast intracystic papillary carcinoma: an update. Breast J (2009) 0.97
Prognostic significance of bcl-xL gene expression and apoptotic cell counts in follicular lymphoma. Blood (2003) 0.96
PRDM1 is involved in chemoresistance of T-cell lymphoma and down-regulated by the proteasome inhibitor. Blood (2008) 0.95
Protective effects of S-nitrosoalbumin on lung injury induced by hypoxia-reoxygenation in mouse model of sickle cell disease. Am J Physiol Lung Cell Mol Physiol (2006) 0.95
Protective effects of phosphodiesterase-4 (PDE-4) inhibition in the early phase of pulmonary arterial hypertension in transgenic sickle cell mice. FASEB J (2008) 0.94
Pericapillary hemorrhage as criterion of severe human digestive graft-versus-host disease. Blood (2004) 0.93
Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells. J Hematol Oncol (2012) 0.93
Fecal calprotectin and alpha-1 antitrypsin predict severity and response to corticosteroids in gastrointestinal graft-versus-host disease. Blood (2012) 0.92
Clinical severity scores in gastrointestinal graft-versus-host disease. Transplantation (2014) 0.92
Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15. Breast Cancer Res (2013) 0.92
BCL-2 inhibition with ABT-737 prolongs survival in an NRAS/BCL-2 mouse model of AML by targeting primitive LSK and progenitor cells. Blood (2013) 0.92
Peripheral T-cell lymphoma with eosinophilia presenting as monoarthritis: a case study. Leuk Lymphoma (2002) 0.92
Clonality analysis of alveolar B lymphocytes contributes to the diagnostic strategy in clinical suspicion of pulmonary lymphoma. Blood (2004) 0.91
Induction of acquired drug resistance in endothelial cells and its involvement in anticancer therapy. J Hematol Oncol (2013) 0.91
Molecular changes in mesothelioma with an impact on prognosis and treatment. Arch Pathol Lab Med (2012) 0.91
Cytostatic and anti-angiogenic effects of temsirolimus in refractory mantle cell lymphoma. J Hematol Oncol (2010) 0.90
Similar tumor suppressor gene alteration profiles in asbestos-induced murine and human mesothelioma. Cell Cycle (2005) 0.89
Cross modulation between the androgen receptor axis and protocadherin-PC in mediating neuroendocrine transdifferentiation and therapeutic resistance of prostate cancer. Neoplasia (2013) 0.89
Human skin carcinoma arising from kidney transplant-derived tumor cells. J Clin Invest (2013) 0.89
Microsatellite instability in urothelial carcinoma of the upper urinary tract. J Urol (2003) 0.89
Numbers of Foxp3-expressing CD4+CD25high T cells do not correlate with the establishment of long-term tolerance after allogeneic stem cell transplantation. Exp Hematol (2005) 0.89
Mirror slides for high-sensitivity cell and tissue fluorescence imaging. J Biomed Opt (2007) 0.88
Neutrophils promote aerogenous spread of lung adenocarcinoma with bronchioloalveolar carcinoma features. Clin Cancer Res (2007) 0.88
Determination of angptl4 mRNA as a diagnostic marker of primary and metastatic clear cell renal-cell carcinoma. PLoS One (2010) 0.88
Arsenic trioxide is effective in the treatment of multiple myeloma in SCID mice. Eur J Haematol (2004) 0.88
p16INK4A inactivation mechanisms in non-small-cell lung cancer patients occupationally exposed to asbestos. Lung Cancer (2010) 0.88
EMMPRIN promotes melanoma cells malignant properties through a HIF-2alpha mediated up-regulation of VEGF-receptor-2. PLoS One (2010) 0.88
Association of CK19 mRNA detection of occult cancer cells in mediastinal lymph nodes in non-small cell lung carcinoma and high risk of early recurrence. Eur J Cancer (2005) 0.87
Presence of microchimerism in labial salivary glands in systemic sclerosis but not in Sjögren's syndrome. Arthritis Rheum (2002) 0.87
Multidrug resistance-associated protein (MRP1) is overexpressed in DNA aneuploid carcinomatous cells in non-small cell lung cancer (NSCLC). Int J Cancer (2005) 0.87
VEGF and VEGFR-1 are coexpressed by epithelial and stromal cells of renal cell carcinoma. Cancer (2008) 0.86
Molecular classification of malignant pleural mesothelioma: identification of a poor prognosis subgroup linked to the epithelial-to-mesenchymal transition. Clin Cancer Res (2014) 0.86
Laser-induced fluorescence as a powerful detection tool for capillary electrophoretic analysis of heparin/heparan sulfate disaccharides. Biomed Chromatogr (2003) 0.86
Value of cytogenetic analysis in the treatment of dermatofibrosarcoma protuberans. J Clin Oncol (2008) 0.86
Acute hepatitis E: a cause of lymphocytic destructive cholangitis. Hum Pathol (2005) 0.85
Differential regulation of sunitinib targets predicts its tumor-type-specific effect on endothelial and/or tumor cell apoptosis. Cancer Chemother Pharmacol (2013) 0.85
Eosinophilic myocarditis and fibrosis. Hum Pathol (2005) 0.84
Chronic bronchial allergic inflammation increases alveolar liquid clearance by TNF-alpha -dependent mechanism. Am J Physiol Lung Cell Mol Physiol (2002) 0.84
Donor-derived keratinocytes in actinic keratosis and squamous cell carcinoma in patients with kidney transplant. J Invest Dermatol (2012) 0.84
Individual xenograft as a personalized therapeutic resort for women with metastatic triple-negative breast carcinoma. Breast Cancer Res (2014) 0.84